Search clinical trials for: Escitalopram Therapy

Total 20732 results

Stanford University
National Institute of Mental Health (NIMH)

Completed

Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome

Insomnia | Major Depressive Disorder

United States
Ryerson University

Unknown

Behavioral Insomnia Therapy For Those With Insomnia and Depression

Insomnia | Major Depressive Disorder

Canada
St. Luke's-Roosevelt Hospital Center
Forest Laboratories

Completed

Escitalopram in the Treatment of Dysthymic Disorder, Double Blind

Dysthymic Disorder

United States
Augusta University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

SAT vs Escitalopram for Rectal Hypersensitivity

Rectal Hypersensitivity | Irritable Bowel Syndrome-Constipation

United States
Emory University
National Institute of Mental Health (NIMH)

Completed

Imaging Predictors of Treatment Response in Depression

Major Depressive Disorder

United States
Hadassah Medical Organization

Completed

Prevention of Post Traumatic Stress Disorder by Early Treatment

Post-traumatic Stress Disorder

Israel
University of Copenhagen
Lundbeck Foundation; Glostrup University Hospital, Copenhagen

Completed

The Effects of Increased Central Serotonergic Activity on Information Processing

Healthy Volunteers

Denmark
First Affiliated Hospital of Zhejiang University

Recruiting

Development and Application of Comprehensive Intervention Techniques for Adolescent Depression

Adolescent | Depressive Disorder

China
University of Nebraska

Recruiting

A Study Utilizing Escitalopram in Glioma Patients

Glioma | Glioma of Brain

United States
Bronx VA Medical Center

Unknown

DBT and Escitalopram in Borderline Personality Disorder

Borderline Personality Disorder

United States
Massachusetts General Hospital
National Alliance for Research on Schizophrenia and Depression

Completed

Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in Depression

Major Depressive Disorder

United States
Robert G. Robinson
National Institute of Mental Health (NIMH)

Completed

Preventing Post-Stroke Depression

Depression | Cerebrovascular Accident

United States
Mayo Clinic
National Institute of General Medical Sciences (NIGMS); National Center for...

Completed

Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram (PGRN-SSRI)

Depression

United States
Centre for Addiction and Mental Health
Queen's University

Completed

Childhood Adversity, Genetic Polymorphisms and Stress in First Onset Major Depression

Depression

Canada
Shanghai 7th People's Hospital

Not yet recruiting

Acupuncture and Escitalopram for Treating Major Depression Clinical Study (AE-TMDCS)

Depressive Disorder, Major

China
Shanghai Mental Health Center
Jiangsu Nhwa Pharmaceutical Co., Ltd.

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in Depression

Depression

China
Taipei Veterans General Hospital, Taiwan
National Tsing Hua University,Taiwan

Completed

Boron Neutron Capture Therapy (BNCT) for Locally Recurrent Head and Neck Cancer (BNCT)

Head and Neck Cancer

Taiwan
New York State Psychiatric Institute
Forest Laboratories

Completed

Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)

Generalized Anxiety Disorder

United States
Shanghai Mental Health Center

Recruiting

A Comparative Study on Efficacy and Safety of add-on Sulforaphane or rTMS to Escitalopram for Major Depressive Disorder With Poor Response to Initial Treatment

Major Depressive Disorder

China
University of Pennsylvania
Washington University School of Medicine

Completed

Escitalopram Effects on CSF Amyloid Beta

Amyloid Beta Protein

United States
Tel Aviv University
Tel-Aviv Sourasky Medical Center; Sheba Medical Center

Completed

Effect of Attention Training or SSRIs on Symptoms and Neural Activation in Social Anxiety

Social Anxiety Disorder

Israel
Veterans Medical Research Foundation
National Institute of Mental Health (NIMH)

Completed

Antidepressant Treatment Plus Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults

Generalized Anxiety Disorder

United States
University of California, Los Angeles

Unknown

Brain Mechanisms and Targeting Insomnia in Major Depression

Insomnia | Major Depressive Disorder

United States
Johns Hopkins University
Medical University of South Carolina; University of South Carolina; University... and other collaborators

Recruiting

Escitalopram and Language Intervention for Subacute Aphasia (ELISA)

Stroke | Aphasia

United States
Emory University
National Institute of Mental Health (NIMH)

Completed

The ISLAND Study: InSuLa Assessed Needs for Depression (ISLAND)

Depression

United States
Oregon Health and Science University
Forest Laboratories

Completed

Circadian Effects of Escitalopram

Depression

United States
Samsung Medical Center
H. Lundbeck A/S

Unknown

Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning

Depression | Adverse Reaction to Drug | Continuous Antidepressant Abuse

Korea, Republic of
Duke University
Forest Laboratories

Completed

Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features

Atypical Depression

United States
Markus KOSEL
University Hospital, Geneva; H. Lundbeck A/S; University Hospital, Basel, Switzerland and other collaborators

Terminated

EScitalopram PIndolol ONset of Action (ESPION)

Unipolar Depression

Switzerland
Massachusetts General Hospital

Completed

Biological Markers of Response to Treatment in Major Depressive Disorder

Major Depressive Disorder
NYU Langone Health
National Institute on Aging (NIA)

Recruiting

Aβ Dynamics in LLMD

Alzheimer Disease | Major Depressive Disorder

United States
KRL Hospital, Islamabad
Dow University of Health Sciences; Khyber Medical College, Peshawar; Quaid-e-Azam...

Completed

Sertraline Versus Escitalopram in South Asian Participants With Moderate to Severe Major Depressive Disorder

Major Depressive Disorder

Pakistan
Laureate Institute for Brain Research, Inc.

Terminated

Adherence to Antidepressant Treatment in Subjects With Depression

Depression

United States
University of Texas Southwestern Medical Center
Takeda Pharmaceuticals North America, Inc.

Terminated

Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon (TAKEDA)

Insomnia | Major Depressive Disorder

United States
University of Texas Southwestern Medical Center
Forest Laboratories

Completed

Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder

Severe Asthma | Moderate or Severe Major Depressive Disorder

United States
University of Washington
National Institutes of Health (NIH); Forest Laboratories

Terminated

Sinusitis and Facial Pain Disorders Anti-Depression Trial (SFPAT)

Depression | Chronic Sinusitis | Facial Pain Disorder

United States
University of Pittsburgh
National Institute of Mental Health (NIMH)

Completed

Treatment of Depression in Adults

Depression

United States, Italy
Milton S. Hershey Medical Center
Takeda Pharmaceuticals North America, Inc.

Terminated

Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for Anxiety

Insomnia | Panic Disorder

United States
University of South Carolina

Completed

Escitalopram (Lexapro) for Depression MS or ALS

Multiple Sclerosis | Amyotrophic Lateral Sclerosis | Major Depression

United States
Max-Planck-Institute of Psychiatry

Completed

Pharmacokinetic and Pharmacodynamic Effects of Escitalopram Depending on Genetic Polymorphisms of the ABCB1-gene

Pharmacokinetics

Germany
University of Pittsburgh
National Institute of Mental Health (NIMH)

Completed

Drug Therapy for Generalized Anxiety Disorder Among the Elderly

Anxiety Disorders | Generalized Anxiety Disorder

United States
Erzurum Regional Training & Research Hospital

Unknown

Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders

Anxiety Disorders | Major Depressive Disorder

Turkey
Xian-Janssen Pharmaceutical Ltd.

Completed

A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom

Depressive Disorder, Major

China
Massachusetts General Hospital
Forest Laboratories

Completed

Escitalopram (Lexapro) for the Treatment of Postpartum Depression (LexaproPPD)

Postpartum Depression

United States
Massachusetts General Hospital

Terminated

SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma Victims

Anxiety Disorder

United States
Forest Laboratories

Completed

Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder

Major Depressive Disorder

United States
Seoul National University Bundang Hospital
Ministry of Health & Welfare, Korea

Unknown

Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive Disorder

Major Depressive Disorder

Korea, Republic of
Duke University

Terminated

A Trial Examining the Efficacy of Escitalopram Oxalate Upon Depressive Symptoms and Fatigue in HIV Seropositive Women

Depression | HIV

United States
Karolinska Institutet

Completed

A PET Study to Determine Alterations in Serotonin Levels in Human Brain After a Single Dose of Escitalopram

Healthy

Sweden
Forest Laboratories

Completed

Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder

Major Depressive Disorder

United States

Search clinical trials for: Escitalopram Therapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations